Source: Clinical genitourinary cancer. Unidade: FM
Subjects: CARCINOMA PAPILAR, ENTORSES E DISTENSÕES, MYCOBACTERIUM BOVIS, IMUNOTERAPIA, NEOPLASIAS DA BEXIGA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
D'ANDREA, David et al. Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer. Clinical genitourinary cancer, v. 18, n. 1, p. 20-+, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clgc.2019.10.021. Acesso em: 09 nov. 2024.APA
D'andrea, D., Soria, F., Abufaraj, M., Pones, M., Gontero, P., Machado, A. T., et al. (2020). Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer. Clinical genitourinary cancer, 18( 1), 20-+. doi:10.1016/j.clgc.2019.10.021NLM
D'andrea D, Soria F, Abufaraj M, Pones M, Gontero P, Machado AT, Waksman R, Enikeev DV, Glybochko PV, Nahas WC. Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer [Internet]. Clinical genitourinary cancer. 2020 ; 18( 1): 20-+.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.clgc.2019.10.021Vancouver
D'andrea D, Soria F, Abufaraj M, Pones M, Gontero P, Machado AT, Waksman R, Enikeev DV, Glybochko PV, Nahas WC. Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer [Internet]. Clinical genitourinary cancer. 2020 ; 18( 1): 20-+.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.clgc.2019.10.021